| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +6% |
| 3Y CAGR | -8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -37% |
| 3Y CAGR | +46% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,736.00 -59.40 (2.12%) | 21,230.07 | 31.31 | 6.3 | ||
PfizerPFIZER | ₹4,070.10 -25.30 (0.62%) | 18,739.41 | 25.49 | 4.46 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,794.00 -66.50 (0.97%) | 17,146.63 | 101.09 | 19.65 | ||
Marksans PharmaMARKSANS | ₹330.50 +0.10 (0.03%) | 14,974.80 | 28.73 | 4.95 |